Search results
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 7 days agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements from officials and academics defending the program.
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 days agoCOLL renegotiated a major Medicare Part D contract for Belbuca, maintaining its access position and...
Republican Senate President Jeb Bradley won’t seek reelection
The Eagle-Tribune· 3 hours agoSenate President Jeb Bradley, R-Wolfeboro, who is also a former U.S. representative, announced he is...
The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook
CW39 NewsFix· 13 hours agoGlobal health company The Cigna Group (NYSE: CI) today reported strong first quarter 2024 results reflecting growth across its diversified portfolio of businesses. "Our strong first quarter ...
CVS reports $1.1B income in Q1, cuts earnings guidance
Becker’s Hospital Review· 2 days agoCVS Health cut its earnings guidance for 2024 based on rising medical costs. CVS Health reported $1.1 billion in net income in the first quarter of 2024, according to its latest earnings documents ...
Novo Nordisk earnings are coming during a weight loss drugs sales surge. Here are 3 things to watch
Quartz· 2 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy,...
'Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse
The Day· 19 hours agoThe American Heart Association calls them "game changers." Oprah Winfrey says they're "a gift." Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. Obesity ...
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...
Benzinga· 2 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 4 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Mirae Asset Global Investments Co. Ltd. Has $630,000 Stake in eHealth, Inc. (NASDAQ:EHTH)
ETF DAILY NEWS· 7 days agoMirae Asset Global Investments Co. Ltd. lifted its stake in shares of eHealth, Inc. (NASDAQ:EHTH – Free Report) by 101.8% in the 4th quarter, according to the company in its most recent filing ...